Skip to content

Cryoablation for Benign Gastrointestinal Anastomotic Strictures

A Randomized Controlled Trial of Cryotherapy on Benign Anastomotic Strictures Following Esophagectomy, Gastrectomy, and Bariatric Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04372784
Enrollment
124
Registered
2020-05-04
Start date
2020-09-30
Completion date
2022-12-31
Last updated
2020-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Stricture of Small Intestine, Duodenal Stricture, Esophageal Stricture, Jejunal Stricture

Brief summary

Anastomotic stricture is a common complication following foregut surgery. The standard of care for these benign foregut anastomotic strictures is balloon dilatation. However, re-stenosis of strictures is also common, requiring frequent repetition of balloon dilatation. Cryotherapy is a novel therapy that may improve clinical outcomes following dilatation. The purpose of the present study is to conduct a randomized controlled trial to characterize the impact of cryotherapy on clinical outcomes and complications for benign anastomotic strictures following esophagectomy, gastrectomy, and bariatric surgery.

Interventions

DEVICECryotherapy

Cryotherapy entails introducing a 9 French catheter via the endoscope's accessory port. The catheter is advanced until it is visualized on the endoscopy monitor. Under 4 psi pressure, liquid nitrogen is sprayed from the catheter for twenty seconds over each four-centimeter segment of stricture

PROCEDUREEsophagogastroduodenoscopy with Balloon Dilatation

This procedure entails deploying a balloon via the accessory port of the esophagogastroduodenoscope under direct visualization and serially inflating the balloon. Balloon dilatation disrupts not only the muscular rings surrounding strictures but also the granulation tissue composing the strictures.

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion Critieria * History of esophagectomywith primary anastomosis * History of gastrectomy with primary anastomosis * History of bariatric surgery with primary anastomosis * History of anastomotic stricture * History of balloon dilatation at Keck Hospital of the University of Southern California Exclusion Critieria * Patients treated at medical centers other than Keck Hospital of the University of Southern California * History of anastomotic stent placement

Design outcomes

Primary

MeasureTime frameDescription
Number of DilatationsOne yearTotal number of dilations within one year

Secondary

MeasureTime frameDescription
Perforation rateImmediately after the intervention/procedure/surgery/etcRates of hollow viscus perforation
Bleeding rateImmediately after the intervention/procedure/surgery/etcRates of clinically significant bleeding
Dilatation sizeImmediately after the intervention/procedure/surgery/etcDilatation size (as a proportion to size at presentation)
ReinterventionOne yearRates of unplanned reintervention (e.g., stenting)
ReadmissionOne yearRates of readmission
Fistula rateOne yearRates of fistula formation

Countries

United States

Contacts

Primary ContactKulmeet Sandhu, MD
kulmeet.sandhu@med.usc.edu323 442 5831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026